V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008061 | 220003227 | 1.82 | null | Curative (C) | 2014-06-10 | 2014-06-11 | Alemtuz+Fludara+Melphalan RIC MUD | 01 | N | 220033732 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008064 | 220003229 | null | null | Curative (C) | 2015-02-18 | 2015-02-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220033737 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008065 | 220003230 | 1.7 | 68 | null | 2017-06-15 | 2017-06-15 | Cisplatin + Radiotherapy | 02 | N | 220033738 | CISPLATIN + RT |
| 220008066 | 220003230 | 1.55 | null | Palliative (P) | 2013-09-01 | 2013-09-02 | Oxaliplatin + Modified de Gramont | N | N | 220033738 | OXALIPLATIN + MDG |
| 220008067 | 220003231 | 1.67 | 87 | null | 2015-03-01 | 2015-03-01 | GEMCITABINE | N | null | 220033741 | PEMBROLIZUMAB |
| 220008068 | 220003232 | 1.81 | null | Curative (C) | 2015-06-01 | 2015-06-14 | FLAG | N | N | 220033744 | FLAG |
| 220008069 | 220003232 | 1.67 | 78.8 | Palliative (P) | 2014-10-18 | 2014-10-18 | EOX | N | N | 220033744 | EOX |
| 220008070 | 220003232 | 1.7 | 56.8 | Curative (C) | 2016-10-04 | 2016-10-04 | ADE 10+3+5 | 02 | N | 220033744 | ADE |
| 220008072 | 220003234 | 1.7 | null | Curative (C) | 2013-05-08 | 2013-06-01 | Cisplatin + Radiotherapy | N | null | 220033759 | CISPLATIN + RT |
| 220008073 | 220003235 | 1.6 | 78 | Curative (C) | 2014-03-20 | 2014-03-20 | AML Int Guide ADE 10+3+5 (1) | N | N | 220033760 | ADE |
| 220008074 | 220011785 | 1.63 | 45.5 | Palliative (P) | 2013-08-18 | 2013-08-19 | Rituximab | N | N | 220033766 | GEMCITABINE |
| 220008075 | 220003236 | 1.65 | 58.6 | Palliative (P) | 2015-10-30 | 2015-11-05 | Oxaliplatin + Modified de Gramont | 02 | Y | 220033768 | OXALIPLATIN + MDG |
| 220008076 | 220003236 | 1.75 | 107 | Palliative (P) | 2015-02-02 | 2015-02-03 | GEMCITABINE | 2 | N | 220033768 | RITUXIMAB |
| 220008077 | 220003236 | 1.5 | 92.6 | null | 2015-03-23 | 2015-03-23 | CAPECITABINE + OXALIPLATIN | 02 | N | 220033768 | CAPECITABINE + OXALIPLATIN |
| 220008078 | 220003236 | 1.84 | null | Curative (C) | 2017-04-18 | 2017-04-25 | Rituximab | null | N | 220033768 | GEMCITABINE |
| 220008079 | 220020456 | null | 92 | Palliative (P) | 2015-12-15 | 2015-12-23 | CARBOPLATIN | N | N | 220033778 | CARBOPLATIN |
| 220008080 | 220020456 | 1.72 | 67.9 | Palliative (P) | null | 2014-07-08 | GEMCITABINE | 2 | N | 220033778 | RAVVA TRIAL |
| 220008081 | 220003237 | 1.73 | 66.7 | Curative (C) | 2014-01-25 | 2014-02-01 | Oxaliplatin + Modified de Gramont | 02 | N | 220033786 | OXALIPLATIN + MDG |
| 220008082 | 220003237 | 1.56 | 67.3 | Curative (C) | 2014-01-16 | 2014-01-16 | ADE | N | N | 220033786 | ADE |
| 220008083 | 220003238 | 1.69 | 92.8 | Curative (C) | null | 2016-12-23 | Cytarabine High Dose | 02 | N | 220033794 | CYTARABINE HIGH DOSE |
| 220008085 | 220003239 | 1.66 | 53.1 | Palliative (P) | 2017-12-18 | 2017-12-18 | Rituximab | 2 | N | 220033800 | RAVVA TRIAL |
| 220008086 | 220003239 | 1.6 | null | Palliative (P) | 2014-08-26 | 2014-09-22 | ECX | N | N | 220033800 | ECX |
| 220008087 | 220003240 | 0 | 74 | Curative (C) | 2014-07-07 | 2014-07-07 | AML Int Guide ADE 10+3+5 (1) | 02 | N | 220033805 | ADE |
| 220008088 | 220003240 | 1.55 | 58.3 | Curative (C) | 2013-12-16 | 2014-01-01 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 220033805 | CISPLATIN + RT |
| 220008089 | 220003240 | 1.8 | 60 | Palliative (P) | 2016-07-21 | 2016-07-22 | FLUOROURACIL + OXALIPLATIN | N | N | 220033805 | OXALIPLATIN + MDG |
| 220008090 | 220003240 | 1.75 | 69.6 | Curative (C) | 2018-01-04 | 2018-01-15 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220033805 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008091 | 220003241 | 1.8 | 89.1 | Curative (C) | null | 2015-02-11 | Cytarabine High Dose | N | N | 220033810 | CYTARABINE HIGH DOSE |
| 220008092 | 220003242 | null | 46.9 | Palliative (P) | 2013-03-16 | 2013-04-13 | CARBOPLATIN | N | N | 220033812 | CARBOPLATIN |
| 220008093 | 220003242 | 1.84 | 77.8 | Palliative (P) | 2013-02-14 | 2014-02-14 | CARBOPLATIN | 02 | N | 220033812 | CARBOPLATIN |
| 220008094 | 220003242 | 1.62 | 106.8 | Palliative (P) | 2013-03-20 | 2013-03-20 | Capecitabine + Oxaliplatin 21day | 02 | N | 220033812 | CAPECITABINE + OXALIPLATIN |
| 220008095 | 220018955 | 1.79 | 82 | Palliative (P) | 2014-08-24 | 2014-08-31 | CAPECITABINE + OXALIPLATIN | N | N | 220033818 | CAPECITABINE + OXALIPLATIN |
| 220008096 | 220003243 | 1.45 | 63.8 | Palliative (P) | 2015-12-25 | 2015-12-25 | PEMBROLIZUMAB | N | N | 220033820 | GEMCITABINE |
| 220008097 | 220011792 | 1.79 | 87 | null | 2015-02-23 | 2015-03-07 | EOX | N | N | 220033824 | EOX |
| 220008098 | 220016345 | null | 76.5 | Curative (C) | 2014-06-10 | 2014-06-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220033826 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008099 | 220016345 | 1.65 | 67.2 | null | 2014-11-25 | 2014-12-09 | ECX | N | N | 220033826 | ECX |
| 220008100 | 220016345 | 1.66 | 106 | Palliative (P) | 2017-02-16 | 2017-03-08 | EOX | Y | N | 220033826 | EOX |
| 220008101 | 220003244 | 1.55 | 50.8 | null | 2016-10-04 | 2016-10-04 | ADE | 2 | N | 220033831 | ADE |
| 220008102 | 220003244 | 1.8 | null | Palliative (P) | 2015-08-27 | 2015-08-27 | Rituximab | null | null | 220033831 | RAVVA TRIAL |
| 220008103 | 220003244 | 1.87 | 73 | Not known (9) | 2015-11-30 | 2015-12-02 | Cytarabine High Dose | N | N | 220033831 | CYTARABINE HIGH DOSE |
| 220008105 | 220003246 | 1.82 | 90.9 | Palliative (P) | null | 2016-12-02 | Carboplatin AUC 2 - 5 | null | null | 220033838 | CARBOPLATIN |
| 220008106 | 220003247 | 1.75 | null | Palliative (P) | 2017-09-13 | 2017-09-13 | Capecitabine + Oxaliplatin 21day | 2 | N | 220033841 | CAPECITABINE + OXALIPLATIN |
| 220008107 | 220003248 | 1.65 | 81.4 | Disease modification (D) | 2017-03-18 | 2017-04-09 | ECX | null | null | 220033843 | ECX |
| 220008108 | 220003248 | 1.87 | 100 | Curative (C) | 2015-11-24 | 2015-11-24 | Cisplatin + Radiotherapy | N | null | 220033843 | CISPLATIN + RT |
| 220008109 | 220003249 | 1.8 | 89.1 | Palliative (P) | 2014-11-15 | 2014-11-15 | EOX | N | N | 220033845 | EOX |
| 220008110 | 220003249 | 1.61 | 4.7 | Palliative (P) | 2017-03-03 | 2017-03-08 | Capecitabine + Oxaliplatin 21day | 2 | N | 220033845 | CAPECITABINE + OXALIPLATIN |
| 220008111 | 220016347 | 1.78 | 117.4 | null | 2013-07-15 | 2017-03-12 | FLAG | 2 | N | 220033849 | FLAG |
| 220008112 | 220003250 | 0 | null | Curative (C) | 2017-09-25 | 2017-09-25 | AML Int Guide ADE 10+3+5 (1) | N | null | 220033850 | ADE |
| 220008113 | 220011796 | null | 69.5 | null | 2014-06-28 | 2014-07-05 | ECX | N | N | 220033851 | ECX |
| 220008114 | 220011796 | null | 74.2 | Palliative (P) | 2017-02-26 | 2017-02-27 | Oxaliplatin + Modified de Gramont | N | N | 220033851 | OXALIPLATIN + MDG |
| 220008115 | 220011796 | 1.61 | 81 | null | null | 2013-01-17 | Cytarabine High Dose | N | N | 220033851 | CYTARABINE HIGH DOSE |